BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3754269)

  • 1. Suppression of natural killer cell activity by human seminal plasma in vitro: identification of 19-OH-PGE as the suppressor factor.
    Tarter TH; Cunningham-Rundles S; Koide SS
    J Immunol; 1986 Apr; 136(8):2862-7. PubMed ID: 3754269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of factors in seminal plasma responsible for suppression of natural killer cell activity.
    Vallely PJ; Sharrard RM; Rees RC
    Immunology; 1988 Mar; 63(3):451-6. PubMed ID: 3350580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of natural and activated human antitumour cytotoxicity by human seminal plasma.
    Rees RC; Vallely P; Clegg A; Potter CW
    Clin Exp Immunol; 1986 Mar; 63(3):687-95. PubMed ID: 2423280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by seminal prostaglandins.
    Quayle AJ; Kelly RW; Hargreave TB; James K
    Clin Exp Immunol; 1989 Mar; 75(3):387-91. PubMed ID: 2702780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal plasma modulates lymphokine-activated killer cell activity in vitro.
    Cardoso E; Arregger A; Coumroglon M; Andrada EC; Andrada JA
    Minerva Endocrinol; 1993 Sep; 18(3):109-14. PubMed ID: 8183177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seminal plasma suppression of human lymphocyte responses in vitro requires the presence of bovine serum factors.
    Vallely PJ; Rees RC
    Clin Exp Immunol; 1986 Oct; 66(1):181-7. PubMed ID: 3492315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components in seminal plasma regulating sperm transport and elimination.
    Troedsson MH; Desvousges A; Alghamdi AS; Dahms B; Dow CA; Hayna J; Valesco R; Collahan PT; Macpherson ML; Pozor M; Buhi WC
    Anim Reprod Sci; 2005 Oct; 89(1-4):171-86. PubMed ID: 16102920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression by seminal plasma from fertile and infertile men: inhibition of natural killer cell function correlates with seminal PG concentration.
    Kelly RW; Quayle AJ; Wallace EM; Wu FC; Hargreave TB; James K
    Prostaglandins Leukot Essent Fatty Acids; 1991 Apr; 42(4):257-60. PubMed ID: 1871176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.